VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AIZN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AIZNAssurant, Inc. 5.25% Subordinat
$19.00$944M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAIZNQuarterly Financials

Assurant, Inc. 5.25% Subordinat (AIZN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Assurant, Inc. 5.25% Subordinat (AIZN) quarterly income statement — complete revenue, gross profit & net income history

AIZN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue3.42B3.35B3.23B3.16B3.07B3.1B2.97B2.92B2.88B2.98B2.77B2.73B2.64B2.65B2.55B2.51B2.48B2.57B2.64B2.54B
Revenue Growth %11.26%7.91%8.89%7.98%6.73%4.08%6.98%7.08%8.98%12.45%8.87%8.84%6.45%3.03%-3.4%-1.28%2.06%0.85%10.99%9.06%
Medical Costs & Claims769.1M717M709.6M721.5M779.7M670.5M776.8M696.1M623.1M599.1M644.6M632.5M645.6M599.3M670.5M600M490M1.45B1.58B1.53B
Medical Cost Ratio %22.49%21.4%21.96%22.84%25.36%21.6%26.18%23.8%21.63%20.08%23.24%23.15%24.43%22.59%26.31%23.91%19.74%56.18%60.01%60.05%
Gross Profit2.65B2.63B2.52B2.44B2.29B2.43B2.19B2.23B2.26B2.38B2.13B2.1B2B2.05B1.88B1.91B1.99B1.13B1.05B1.02B
Gross Margin %77.51%78.6%78.04%77.16%74.64%78.4%73.82%76.2%78.37%79.92%76.76%76.85%75.57%77.41%73.69%76.09%80.26%43.82%39.99%39.95%
Gross Profit Growth %15.55%8.18%15.11%9.34%1.65%2.11%2.88%6.18%13.01%16.09%13.42%9.92%0.23%82%78%88.02%108.18%14.39%30.08%7.98%
Operating Expenses2.32B2.35B2.19B2.15B2.11B2.18B2.04B2B1.96B2.16B1.9B1.89B1.85B1.96B1.87B1.84B1.82B966.5M866.6M776M
OpEx / Revenue %67.7%70.14%67.79%68.01%68.66%70.35%68.72%68.24%68.2%72.32%68.52%69.37%70.01%73.78%73.34%73.31%73.21%37.54%32.85%30.52%
Depreciation & Amortization072M62.3M59M56.7M63.9M58.5M50.5M50.6M55.2M45.9M47.2M48.1M41.8M44.8M48.1M47.3M45.6M41.9M42.7M
Combined Ratio %90.19%91.54%89.75%90.85%94.02%91.95%94.9%92.04%89.83%92.4%91.75%92.52%94.43%96.37%99.66%97.21%92.94%93.72%92.87%90.57%
Operating Income335.6M283.5M331.2M289M183.7M250M151.5M232.9M292.9M226.6M228.8M204.3M147.1M96.3M8.7M69.9M175.2M161.8M188.2M239.7M
Operating Margin %9.81%8.46%10.25%9.15%5.98%8.05%5.1%7.96%10.17%7.6%8.25%7.48%5.57%3.63%0.34%2.79%7.06%6.28%7.13%9.43%
Operating Income Growth %82.69%13.4%118.61%24.09%-37.28%10.33%-33.78%14%99.12%135.31%2529.89%192.27%-16.04%-40.48%-95.38%-70.84%-9.27%-11.78%67.29%14.52%
EBITDA335.6M355.5M393.5M348M240.4M313.9M210M283.4M343.5M281.8M274.7M251.5M195.2M138.1M53.5M118M222.5M207.4M230.1M282.4M
EBITDA Margin %9.81%10.61%12.18%11.02%7.82%10.11%7.08%9.69%11.93%9.45%9.9%9.21%7.39%5.21%2.1%4.7%8.96%8.05%8.72%11.11%
Interest Expense28.3M28.3M27.9M26.7M26.8M26.8M26.7M26.7M26.8M26.8M27M27.2M27M27.9M26.3M27.2M26.9M27.1M27.5M28.8M
Non-Operating Income-28.3M-28.3M-27.9M-26.7M-26.8M-26.8M-26.7M-26.7M-26.8M-26.8M-27M-27.2M-27M-27.9M-26.1M-27.2M-26.9M-27.1M-27.5M-28.8M
Pretax Income335.6M283.5M331.2M289M183.7M250M151.5M232.9M292.9M226.6M228.8M204.3M147.1M96.3M8.5M69.9M175.2M161.8M188.2M239.7M
Pretax Margin %9.81%8.46%10.25%9.15%5.98%8.05%5.1%7.96%10.17%7.6%8.25%7.48%5.57%3.63%0.33%2.79%7.06%6.28%7.13%9.43%
Income Tax61.5M58.3M65.6M53.7M37.1M48.7M17.7M44.2M56.5M44.1M38.7M48M33.5M28.2M1.2M17.7M26.2M35.1M37.2M52.6M
Effective Tax Rate %18.33%20.56%19.81%18.58%20.2%19.48%11.68%18.98%19.29%19.46%16.91%23.49%22.77%29.28%14.12%25.32%14.95%21.69%19.77%21.94%
Net Income274.1M225.2M265.6M235.3M146.6M201.3M133.8M188.7M236.4M182.5M190.1M156.3M113.6M68.1M7.3M52.2M149M123.6M879.8M205.8M
Net Margin %8.01%6.72%8.22%7.45%4.77%6.48%4.51%6.45%8.21%6.12%6.85%5.72%4.3%2.57%0.29%2.08%6%4.8%33.35%8.1%
Net Income Growth %86.97%11.87%98.51%24.7%-37.99%10.3%-29.62%20.73%108.1%167.99%2504.11%199.43%-23.76%-44.9%-99.17%-74.64%-8.59%-11.21%3013.24%15.55%
EPS (Diluted)5.464.495.174.562.833.872.553.584.473.423.542.902.121.270.140.952.652.2014.793.36
EPS Growth %92.93%16.02%102.75%27.37%-36.69%13.16%-27.97%23.45%110.85%169.29%2428.57%205.26%-20%-42.27%-99.05%-71.73%0.38%-1.35%2650%19.57%
EPS (Basic)5.514.495.224.602.863.892.563.594.503.443.552.912.121.270.140.962.672.2114.883.38
Diluted Shares Outstanding50.2M50.2M51.32M51.57M51.73M52.08M52.46M52.72M52.87M53.43M53.75M53.89M53.7M53.77M54.07M55.01M56.18M57.73M59.48M61.32M